Estimated Out-of-Pocket Costs for Patients With Common Cancers and Private Insurance

What are the out-of-pocket costs associated with the initial treatment of breast, colorectal, and lung cancer at different stages among privately insured individuals?In this cohort study of 46 158 privately insured individuals younger than 65 years, an incident diagnosis of breast, colorectal, or lung cancer was associated with an increase in out-of-pocket costs of $592.53 per month during the 6 months after diagnosis, with costs increasing by stage at diagnosis.This study found that privately insured patients with newly diagnosed cancer, particularly those with more advanced disease, had substantial out-of-pocket costs.

Corresponding Author: Liam Rose, PhD, Stanford University School of Medicine, 3145 Porter Dr, Wing C0, Palo Alto, CA 94304 (liamrose@stanford.edu).

Link to the article in your story

We encourage you to link out to this article in your your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.